Healthcare & Medical Devices Global On demand · 24-48h

Global AI-enabled Medical Imaging Diagnostic Software Market Strategic Research Report

Global AI-enabled Medical Imaging Diagnostic Software Market…
$3,500 USD
Market Research Reports
Strategic Research Report
Global AI-enabled Medical Imaging Diagnostic Software Market
$2.09B2025
16.3%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: CT Imaging AI, X-ray Imaging AI, MRI Imaging AI, Ultrasound Imaging AI, Mammography AI, Multimodal Imaging AI, Other

By Application: Hospitals, Imaging Centers, Teleradiology Networks, Public Health Programs, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Aidoc, Viz.ai, Lunit, Qure.ai, DeepHealth, Siemens Healthineers, GE HealthCare, Philips, United Imaging Intelligence, Infervision, Coreline Soft, Blackford Analysis

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 105 pages
Market size 2025
$2.09B
Billion USD
Forecast CAGR
16.3%
2025-2032
Forecast 2032
$6B
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global AI-enabled Medical Imaging Diagnostic Software market size is predicted to grow from US$ 2,089 million in 2025 to US$ 5,986 million in 2032; it is expected to grow at a CAGR of 16.3% from 2026 to 2032.

AI-enabled medical imaging diagnostic software combines deep learning, computer vision and imaging workflow integration to support lesion detection, quantitative analysis, risk stratification, reporting assistance and triage across CT, X-ray, MRI, ultrasound and mammography data. These products are commonly integrated with PACS, RIS, imaging cloud platforms and hospital information systems, with emphasis on reading efficiency, early screening capability, diagnostic consistency and faster response to critical findings. The average gross profit margin of this product is 55%.

The global market for AI-enabled medical imaging diagnostic software is moving from single-algorithm pilots toward routine integration into hospital imaging workflows. Shortages of radiologists, rising examination volumes and accumulation of multimodal imaging data are pushing hospitals to adopt solutions that can embed into PACS/RIS, triage critical cases and reduce repetitive work.

Competition is expanding from single-disease detection to multi-disease, multi-organ and multimodality platform capability. Stroke, lung nodules, breast screening, fracture detection, cardiovascular imaging and emergency chest imaging are among the more commercialized areas, while vendors must demonstrate clinical effectiveness, workflow compatibility and regulatory compliance.

Growth is driven by higher imaging demand, hospital digitalization, clearer regulatory pathways for medical AI and expansion of screening programs. Pricing remains affected by hospital budgets, software subscription models and reimbursement uncertainty, but companies with real-world validation, large-scale deployment experience and cloud delivery capability are better positioned to generate scalable revenue.

This report presents a comprehensive overview of the global AI-enabled Medical Imaging Diagnostic Software market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • CT Imaging AI
  • X-ray Imaging AI
  • MRI Imaging AI
  • Ultrasound Imaging AI
  • Mammography AI
  • Multimodal Imaging AI
  • Other

Segment by Clinical Area

  • Neurology
  • Oncology
  • Cardiovascular
  • Respiratory
  • Breast Imaging
  • Emergency Triage
  • Other

Segment by Deployment

  • Cloud-based
  • On-premise
  • Hybrid
  • Edge Device
  • Other

Segment by Application

  • Hospitals
  • Imaging Centers
  • Teleradiology Networks
  • Public Health Programs
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global AI-enabled Medical Imaging Diagnostic Software market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospitals, Imaging Centers, Teleradiology Networks evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global AI-enabled Medical Imaging Diagnostic Software Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 16.3%
Regional growth momentum
Market share by segment
Key metrics
Base value
$2.09B
2025
Forecast
$6B
2032
CAGR
16.3%
2025–2032
Regions
5
global
Key companies
AidocViz.aiLunitQure.aiDeepHealthSiemens HealthineersGE HealthCarePhilips
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
CT Imaging AIX-ray Imaging AIMRI Imaging AIUltrasound Imaging AIMammography AIMultimodal Imaging AIOther
By Application
HospitalsImaging CentersTeleradiology NetworksPublic Health ProgramsOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 CT Imaging AI
  • 3.1.3 X-ray Imaging AI
  • 3.1.4 MRI Imaging AI
  • 3.1.5 Ultrasound Imaging AI
  • 3.1.6 Mammography AI
  • 3.1.7 Multimodal Imaging AI
  • 3.1.8 Other
  • 3.1.9 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospitals
  • 4.1.3 Imaging Centers
  • 4.1.4 Teleradiology Networks
  • 4.1.5 Public Health Programs
  • 4.1.6 Other
  • 4.1.7 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Aidoc
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Viz.ai
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Lunit
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Qure.ai
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 DeepHealth
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Siemens Healthineers
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 GE HealthCare
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Philips
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 United Imaging Intelligence
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Infervision
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Coreline Soft
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Blackford Analysis
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global AI-enabled Medical Imaging Diagnostic Software market size?
The global AI-enabled Medical Imaging Diagnostic Software market is estimated at US$ 2.09 billion in 2025 (base year) and is projected to reach US$ 5.99 billion by 2032.
What growth rate is expected for the AI-enabled Medical Imaging Diagnostic Software market through 2032?
The market is expected to grow at a CAGR of 16.3% from 2026 to 2032, expanding from US$ 2.09 billion in 2025 to US$ 5.99 billion in 2032, roughly 2.9 times its base-year value.
How is AI-enabled Medical Imaging Diagnostic Software defined?
AI-enabled medical imaging diagnostic software combines deep learning, computer vision and imaging workflow integration to support lesion detection, quantitative analysis, risk stratification, reporting assistance and triage across CT, X-ray, MRI, ultrasound and mammography data. These products are commonly integrated with PACS, RIS, imaging cloud platforms and hospital information systems, with emphasis on reading efficiency, early screening capability, diagnostic consistency and faster response to critical findings.
How is the AI-enabled Medical Imaging Diagnostic Software market segmented by type?
By type, the market is segmented into CT Imaging AI, X-ray Imaging AI, MRI Imaging AI, Ultrasound Imaging AI, Mammography AI, Multimodal Imaging AI and Other.
What are the key applications of AI-enabled Medical Imaging Diagnostic Software?
Key applications covered include Hospitals, Imaging Centers, Teleradiology Networks, Public Health Programs and Other.
Which companies are profiled in the AI-enabled Medical Imaging Diagnostic Software market report?
Key players profiled include Aidoc, Viz.ai, Lunit, Qure.ai, DeepHealth, Siemens Healthineers, GE HealthCare and Philips, among 12 companies covered in total.
What geographies does the AI-enabled Medical Imaging Diagnostic Software market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for AI-enabled Medical Imaging Diagnostic Software?
Growth is driven by higher imaging demand, hospital digitalization, clearer regulatory pathways for medical AI and expansion of screening programs.
Who should buy the AI-enabled Medical Imaging Diagnostic Software market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospitals, Imaging Centers and Teleradiology Networks, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the AI-enabled Medical Imaging Diagnostic Software market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.